Home/Filings/4/0001094891-20-000066
4//SEC Filing

Aklog Lishan 4

Accession 0001094891-20-000066

CIK 0001624326other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 5:25 PM ET

Size

9.8 KB

Accession

0001094891-20-000066

Insider Transaction Report

Form 4
Period: 2020-04-30
Aklog Lishan
DirectorChairman and CEO
Transactions
  • Award

    Common Stock

    2020-04-30+250,0001,098,413 total
Holdings
  • Common Stock

    (indirect: By son)
    2,280
  • Common Stock

    (indirect: By LLC)
    20,000
  • Common Stock

    (indirect: By daughter)
    2,303
  • Common Stock

    (indirect: By LLC)
    4,456,570
Transactions
  • Award

    Common Stock

    2020-04-30+250,0001,098,413 total
Holdings
  • Common Stock

    (indirect: By son)
    2,280
  • Common Stock

    (indirect: By daughter)
    2,303
  • Common Stock

    (indirect: By LLC)
    4,456,570
  • Common Stock

    (indirect: By LLC)
    20,000
Footnotes (3)
  • [F1]The issuer granted 250,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan.
  • [F2]Dr. Aklog is a member and sole manager of Pavilion Venture Partners LLC, and has sole voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein.
  • [F3]Dr. Aklog is a co-manager of HCFP/AG LLC, and shares joint voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his pecuniary interest therein.

Issuer

PAVmed Inc.

CIK 0001624326

Entity typeother

Related Parties

1
  • filerCIK 0001665074

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 5:25 PM ET
Size
9.8 KB